Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma

Surgery Today
Hiroshi SaekiYoshihiko Maehara

Abstract

The significance of neoadjuvant chemoradiotherapy (NACRT) for esophageal squamous cell carcinoma (ESCC) remains controversial with regard to the pathological response and long-term survival. We herein review the current status of and future perspectives regarding NACRT followed by esophagectomy for locally advanced ESCC. Some studies have suggested that a pathological complete response with NACRT is more common in patients with ESCC than in those with adenocarcinoma and that NACRT provided a survival benefit limited to patients with ESCC. However, NACRT may increase the risk of postoperative complications after esophagectomy. It is obvious that a favorable pathological response is the most important factor for obtaining a survival benefit, although no established parameters have been implemented clinically to predict the response to NACRT. Prospective clinical studies and basic research studies to identify predictive biomarkers for the response to NACRT are needed to aid in the development of NACRT treatment strategies for patients with ESCC.

References

May 8, 1992·Science·S E KernB Vogelstein
Mar 1, 1995·World Journal of Surgery·U FinkJ R Siewert
Aug 11, 1998·Trends in Biochemical Sciences·P Baumann, S C West
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A OhtsuA Nakamura
Feb 24, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S G UrbaM Strawderman
Oct 31, 2001·Molecular Cell·A SlupianekT Skorski
Mar 20, 2002·The Annals of Thoracic Surgery·Christopher E AvendanoCarolyn E Reed
Jan 8, 2004·British Journal of Cancer·T D L CrosbyT S Maughan
Mar 17, 2004·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Scott T KelleyRichard C Karl
Jul 16, 2004·Plastic and Reconstructive Surgery·Minoru SakurabaSatoshi Ebihara
Oct 30, 2004·The Annals of Thoracic Surgery·Frank C-F LinMark K Ferguson
Jan 28, 2005·Surgery·Sarah E GreerJohn D Birkmeyer
Mar 23, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam C BergerMelvyn Goldberg
Sep 1, 2005·The Lancet Oncology·Bryan H BurmeisterUNKNOWN Australasian Gastro-Intestinal Trials Group
May 30, 2006·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi SaekiMaria Jasin
Oct 31, 2006·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·S NatsugoeT Aikou
Dec 21, 2006·Seminars in Oncology·Rajyalakshmi LuthraJaffer A Ajani
Mar 3, 2007·The Lancet Oncology·Val GebskiUNKNOWN Australasian Gastro-Intestinal Trials Group
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joel TepperRobert Mayer
Aug 26, 2009·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·X-F CaoJ Lv
Apr 1, 2010·World Journal of Gastroenterology : WJG·Jin LvDong Dong Wang
Feb 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroshi SaekiYoshihiko Maehara
Sep 29, 2011·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·W-H ChenH-P Liu
Jun 1, 2012·The New England Journal of Medicine·P van HagenUNKNOWN CROSS Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Related Papers

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
M TachibanaN Nagasue
© 2022 Meta ULC. All rights reserved